43742-2203 NDC - ENERGY CATALYST (ADENOSINUM CYCLOPHOSPHORICUM, ALUMINA, ARSENICUM ALBUM, CERIUM OXALICUM, COBALT GLUCONATE, CUPRUM SULPHURICUM, CALCAREA PHOSPHORICA, CHROMIUM METALLICUM, COBALTUM METALLICUM, CUPRUM METALLICUM, FERRUM METALLICUM, IODIUM, IRIDIUM METALLICUM, KALI CARBONICUM, LITHIUM CARBONICUM, MAGNESIUM METALLICUM, MANGANUM METALLICUM, MOLYBDENUM, NATRUM MURIATICUM, PHOSPHORUS, SELENIUM METALLICUM, STRONTIUM CARBONICUM, SULPHUR, VANADIUM METALLICUM, ZINCUM METALLICUM, ALUMINIUM METALLICUM, ANTIMONIUM CRUDUM,)

Drug Information

  • Product NDC: 43742-2203
  • Proprietary Name: Energy Catalyst
  • Non Proprietary Name: Adenosinum Cyclophosphoricum, Alumina, Arsenicum Album, Cerium Oxalicum, Cobalt Gluconate, Cuprum Sulphuricum, Calcarea Phosphorica, Chromium Metallicum, Cobaltum Metallicum, Cuprum Metallicum, Ferrum Metallicum, Iodium, Iridium Metallicum, Kali Carbonicum, Lithium Carbonicum, Magnesium Metallicum, Manganum Metallicum, Molybdenum, Natrum Muriaticum, Phosphorus, Selenium Metallicum, Strontium Carbonicum, Sulphur, Vanadium Metallicum, Zincum Metallicum, Aluminium Metallicum, Antimonium Crudum,
  • Active Ingredient(s): 8 [hp_X]/mL ADENOSINE CYCLIC PHOSPHATE; 12 [hp_X]/mL ALUMINUM; 30 [hp_X]/mL ALUMINUM OXIDE; 12 [hp_X]/mL ANTIMONY TRISULFIDE; 12 [hp_X]/mL ARSENIC TRIOXIDE; 12 [hp_X]/mL BARIUM CARBONATE; 12 [hp_X]/mL BERYLLIUM; 12 [hp_X]/mL BISMUTH; 12 [hp_X]/mL BROMINE; 12 [hp_X]/mL CADMIUM; 12 [hp_X]/mL CERIUM; 8 [hp_X]/mL CEROUS OXALATE NONAHYDRATE; 12 [hp_X]/mL CESIUM CHLORIDE; 8 [hp_X]/mL CHOLECALCIFEROL; 8 [hp_X]/mL CHROMIUM; 8 [hp_X]/mL COBALT; 6 [hp_X]/mL COBALTOUS GLUCONATE; 8 [hp_X]/mL COPPER; 6 [hp_X]/mL CUPRIC SULFATE; 12 [hp_X]/mL DYSPROSIUM; 12 [hp_X]/mL ERBIUM; 12 [hp_X]/mL EUROPIUM; 6 [hp_X]/mL FERROUS FUMARATE; 12 [hp_X]/mL GADOLINIUM; 12 [hp_X]/mL GERMANIUM SESQUIOXIDE; 12 [hp_X]/mL GOLD; 12 [hp_X]/mL HOLMIUM; 12 [hp_X]/mL INDIUM; 8 [hp_X]/mL IODINE; 8 [hp_X]/mL IRIDIUM; 8 [hp_X]/mL IRON; 14 [hp_C]/mL LANTHANUM; 12 [hp_X]/mL LEAD; 8 [hp_X]/mL LITHIUM CARBONATE; 8 [hp_X]/mL MAGNESIUM; 6 [hp_X]/mL MAGNESIUM ASPARTATE; 8 [hp_X]/mL MANGANESE; 6 [hp_X]/mL MANGANESE GLUCONATE; 30 [hp_X]/mL MERCURIC CHLORIDE; 12 [hp_X]/mL MERCURIUS SOLUBILIS; 8 [hp_X]/mL MOLYBDENUM; 12 [hp_X]/mL NEODYMIUM OXIDE; 12 [hp_X]/mL NICKEL; 8 [hp_X]/mL NICKEL ACETATE; 30 [hp_C]/mL NIOBIUM; 12 [hp_X]/mL OSMIUM; 12 [hp_X]/mL PALLADIUM; 6 [hp_X]/mL PHOSPHORUS; 12 [hp_X]/mL PLATINUM; 6 [hp_X]/mL POTASSIUM ASPARTATE; 8 [hp_X]/mL POTASSIUM CARBONATE; 12 [hp_X]/mL PRASEODYMIUM; 30 [hp_C]/mL PROTEUS MORGANII; 12 [hp_X]/mL RHODIUM; 12 [hp_X]/mL RUBIDIUM NITRITE; 12 [hp_X]/mL SAMARIUM; 8 [hp_X]/mL SELENIUM; 12 [hp_X]/mL SILVER; 8 [hp_X]/mL SODIUM CHLORIDE; 6 [hp_X]/mL SODIUM MOLYBDATE; 8 [hp_X]/mL STRONTIUM CARBONATE; 8 [hp_X]/mL SULFUR; 30 [hp_C]/mL TANTALUM; 12 [hp_X]/mL TERBIUM; 12 [hp_X]/mL THALLIUM; 12 [hp_X]/mL TIN; 8 [hp_X]/mL TRIBASIC CALCIUM PHOSPHATE; 15 [hp_C]/mL URANYL NITRATE HEXAHYDRATE; 8 [hp_X]/mL VANADIUM; 3 [hp_X]/mL VISCUM ALBUM FRUITING TOP; 12 [hp_X]/mL YTTERBIUM OXIDE; 8 [hp_X]/mL ZINC
  • Administration Route(s): ORAL
  • Dosage Form(s): LIQUID
  • Pharmacy Class(es): Allergens [CS]; Allergens [CS]; Allergens [CS]; Allergens [CS]; Blood Coagulation Factor [EPC]; Calcium [CS]; Calculi Dissolution Agent [EPC]; Cations; Divalent [CS]; Cell-mediated Immunity [PE]; Cell-mediated Immunity [PE]; Cell-mediated Immunity [PE]; Cell-mediated Immunity [PE]; Copper [CS]; Copper-containing Intrauterine Device [EPC]; Decreased Embryonic Implantation [PE]; Decreased Sperm Motility [PE]; Increased Coagulation Factor Activity [PE]; Increased Histamine Release [PE]; Increased Histamine Release [PE]; Increased Histamine Release [PE]; Increased Histamine Release [PE]; Increased Large Intestinal Motility [PE]; Inhibit Ovum Fertilization [PE]; Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]; Inhibition Small Intestine Fluid/Electrolyte Absorption [PE]; Magnesium Ion Exchange Activity [MoA]; Magnetic Resonance Contrast Activity [MoA]; Mood Stabilizer [EPC]; Osmotic Activity [MoA]; Osmotic Laxative [EPC]; Paramagnetic Contrast Agent [EPC]; Phosphate Binder [EPC]; Phosphate Chelating Activity [MoA]; Standardized Chemical Allergen [EPC]; Standardized Chemical Allergen [EPC]; Standardized Chemical Allergen [EPC]; Standardized Chemical Allergen [EPC]; Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]; Vitamin D [CS]; Vitamin D [EPC]

Labeler Information

Field Name Field Value
Labeler Name: Deseret Biologicals, Inc.
Product Type: HUMAN OTC DRUG
FDA Application Number:
Marketing Category: UNAPPROVED HOMEOPATHIC
Start Marketing Date:12/10/2024

Package Information

No. Package Code Package Description Billing Unit
143742-2203-160 mL in 1 BOTTLE, DROPPER (43742-2203-1)

NDC Record

Field Name Field Value Definition
PRODUCT NDC43742-2203The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
PRODUCT TYPE NAMEHUMAN OTC DRUGIndicates the type of product, such as Human Prescription Drug or Human Over the Counter Drug. This data element matches the “Document Type” field of the Structured Product Listing.
PROPRIETARY NAMEEnergy CatalystThe proprietary name also known as the trade name is the name of the product chosen by the medication labeler for marketing purposes.
NON PROPRIETARY NAMEAdenosinum Cyclophosphoricum, Alumina, Arsenicum Album, Cerium Oxalicum, Cobalt Gluconate, Cuprum Sulphuricum, Calcarea Phosphorica, Chromium Metallicum, Cobaltum Metallicum, Cuprum Metallicum, Ferrum Metallicum, Iodium, Iridium Metallicum, Kali Carbonicum, Lithium Carbonicum, Magnesium Metallicum, Manganum Metallicum, Molybdenum, Natrum Muriaticum, Phosphorus, Selenium Metallicum, Strontium Carbonicum, Sulphur, Vanadium Metallicum, Zincum Metallicum, Aluminium Metallicum, Antimonium Crudum,The non-proprietary name is sometimes called the generic name. The generic name usually includes the active ingredient(s) of the product.
DOSAGE FORM NAMELIQUIDThe translation of the dosage form Code submitted by the firm.
ROUTE NAMEORALThe translation of the route code submitted by the firm, indicating route of administration.
START MARKETING DATE12/10/2024This is the date that the labeler indicates was the start of its marketing of the drug product.
MARKETING CATEGORY NAMEUNAPPROVED HOMEOPATHICProduct types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
LABELER NAMEDeseret Biologicals, Inc.Name of Company corresponding to the labeler code segment of the Product NDC.
SUBSTANCE NAMEADENOSINE CYCLIC PHOSPHATE; ALUMINUM; ALUMINUM OXIDE; ANTIMONY TRISULFIDE; ARSENIC TRIOXIDE; BARIUM CARBONATE; BERYLLIUM; BISMUTH; BROMINE; CADMIUM; CERIUM; CEROUS OXALATE NONAHYDRATE; CESIUM CHLORIDE; CHOLECALCIFEROL; CHROMIUM; COBALT; COBALTOUS GLUCONATE; COPPER; CUPRIC SULFATE; DYSPROSIUM; ERBIUM; EUROPIUM; FERROUS FUMARATE; GADOLINIUM; GERMANIUM SESQUIOXIDE; GOLD; HOLMIUM; INDIUM; IODINE; IRIDIUM; IRON; LANTHANUM; LEAD; LITHIUM CARBONATE; MAGNESIUM; MAGNESIUM ASPARTATE; MANGANESE; MANGANESE GLUCONATE; MERCURIC CHLORIDE; MERCURIUS SOLUBILIS; MOLYBDENUM; NEODYMIUM OXIDE; NICKEL; NICKEL ACETATE; NIOBIUM; OSMIUM; PALLADIUM; PHOSPHORUS; PLATINUM; POTASSIUM ASPARTATE; POTASSIUM CARBONATE; PRASEODYMIUM; PROTEUS MORGANII; RHODIUM; RUBIDIUM NITRITE; SAMARIUM; SELENIUM; SILVER; SODIUM CHLORIDE; SODIUM MOLYBDATE; STRONTIUM CARBONATE; SULFUR; TANTALUM; TERBIUM; THALLIUM; TIN; TRIBASIC CALCIUM PHOSPHATE; URANYL NITRATE HEXAHYDRATE; VANADIUM; VISCUM ALBUM FRUITING TOP; YTTERBIUM OXIDE; ZINCAn active ingredient is the substance responsible for the medicinal effects of a product specified by the substance's molecular structure or if the molecular structure is not known, defined by an unambiguous definition that identifies the substance. Each active ingredient name is the preferred term of the UNII code submitted.
ACTIVE NUMERATOR STRENGTH8; 12; 30; 12; 12; 12; 12; 12; 12; 12; 12; 8; 12; 8; 8; 8; 6; 8; 6; 12; 12; 12; 6; 12; 12; 12; 12; 12; 8; 8; 8; 14; 12; 8; 8; 6; 8; 6; 30; 12; 8; 12; 12; 8; 30; 12; 12; 6; 12; 6; 8; 12; 30; 12; 12; 12; 8; 12; 8; 6; 8; 8; 30; 12; 12; 12; 8; 15; 8; 3; 12; 8 
ACTIVE INGRED UNIT[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL 
PHARM CLASSESAllergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Blood Coagulation Factor [EPC], Calcium [CS], Calculi Dissolution Agent [EPC], Cations, Divalent [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Copper [CS], Copper-containing Intrauterine Device [EPC], Decreased Embryonic Implantation [PE], Decreased Sperm Motility [PE], Increased Coagulation Factor Activity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Large Intestinal Motility [PE], Inhibit Ovum Fertilization [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Magnetic Resonance Contrast Activity [MoA], Mood Stabilizer [EPC], Osmotic Activity [MoA], Osmotic Laxative [EPC], Paramagnetic Contrast Agent [EPC], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA], Standardized Chemical Allergen [EPC], Standardized Chemical Allergen [EPC], Standardized Chemical Allergen [EPC], Standardized Chemical Allergen [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE], Vitamin D [CS], Vitamin D [EPC] 

Download Record

Download this NDC record record in Text format: Export

Download this NDC record record in Excel (CSV) format: Export

Download this NDC record record in XML format: Export

This page was last updated on: 12/19/2025

Previous Code
Next Code